Quoin Pharmaceuticals (QNRX) Debt Ratio (2020 - 2023)

Quoin Pharmaceuticals (QNRX) posted Debt Ratio of 0.22 for Q1 2023, down 58.77% sequentially from 0.53 in Q4 2022.

Quoin Pharmaceuticals (QNRX) Debt Ratio (2020 - 2023) Analysis & Trends

Quoin Pharmaceuticals has reported Debt Ratio for 4 years, with the latest figure at 0.22 in Q1 2023.

Quarterly Debt Ratio changed N/A year-over-year to 0.22 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 0.22 (changed N/A YoY) and the FY2022 annual result came in at 0.53, up 4.77% from the prior year.
Debt Ratio declined to 0.22 in Q1 2023 per QNRX's latest filing, from 0.53 in the prior quarter.
Over five years, Debt Ratio peaked at 4.43 in Q4 2020 and troughed at 0.22 in Q1 2023.
A 4-year average of 1.16 and a median of 0.52 in 2022 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2021 and 2022: Debt Ratio slumped 88.6% in 2021, then grew 4.77% in 2022.
Over 4 years, Debt Ratio stood at 4.43 in 2020, then plunged by 88.6% to 0.5 in 2021, then gained by 4.77% to 0.53 in 2022, then plunged by 58.77% to 0.22 in 2023.
According to Business Quant data, Debt Ratio over the past three periods registered 0.22, 0.53, and 0.26 for Q1 2023, Q4 2022, and Q3 2022 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	139.95 Bn	132.10 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.71 Bn	78.72 Bn	3.93 Bn	0.05
3	Argenx Se	65.71 Bn	60.52 Bn	1.37 Bn	-
4	Moderna	60.45 Bn	55.31 Bn	52.00 Mn	0.05
5	BeOne Medicines	42.24 Bn	37.14 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.80 Bn	28.49 Bn	992.69 Mn	-
7	BioNTech SE	28.64 Bn	10.25 Bn	668.28 Mn	0.03
8	Insmed	27.61 Bn	26.45 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.26 Bn	26.42 Bn	-	0.47
10	Quoin Pharmaceuticals	500,481.67	500,481.67	-	-

Download Data